SCHEMBL21591745

SCHEMBL21591745

CC(C)(C)OC(=O)N1CCN(c2ccc3c(c2)CN(C(=O)O)C3)[C@H](CO)C1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 1/20 0.44
ESR2 Q92731 1/20 0.44
NR1H2 P55055 2/20 0.43
NAMPT P43490 3/20 0.41
DDB1 Q16531 1/20 0.40
CRBN Q96SW2 1/20 0.40
HTR1A P08908 1/20 0.37
ADRA2A P08913 1/20 0.37
ADRA2B P18089 1/20 0.37
ADRA2C P18825 1/20 0.37
DRD1 P21728 1/20 0.37
HRH2 P25021 1/20 0.37
HTR1B P28222 1/20 0.37
HTR2A P28223 1/20 0.37
HTR2C P28335 1/20 0.37
HTR1E P28566 1/20 0.37
SLC6A4 P31645 1/20 0.37
HRH1 P35367 1/20 0.37
HTR2B P41595 1/20 0.37
TMEM97 Q5BJF2 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21800237 0.87 TMEM97 (0.56) HTR1AADRA2AADRA2BADRA2CDRD1
SCHEMBL23854712 0.87 TMEM97 (0.56) HTR1AADRA2AADRA2BADRA2CDRD1
SCHEMBL21360338 0.81 GPR119 (0.52) NR1H2NAMPTGPR119USP30
SCHEMBL8236259 0.81 GPR119 (0.52) NR1H2NAMPTGPR119USP30
SCHEMBL6719383 0.80 GPR119 (0.43) ESR2NR1H2GPR119ALDH1A1LMNA
SCHEMBL6719421 0.80 GPR119 (0.43) ESR2NR1H2GPR119ALDH1A1LMNA
SCHEMBL21360346 0.79 GRM5 (0.42) HDAC1NR1H2GPR119ALDH1A1LMNA
SCHEMBL16825013 0.79 NR1H2 (0.44) NR1H2GPR119ALDH1A1LMNAMAPT
SCHEMBL18186285 0.79 NR1H2 (0.44) NR1H2GPR119ALDH1A1LMNAMAPT
SCHEMBL14921110 0.79 CNR1 (0.51) NR1H2GPR119ALDH1A1LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3807270-A1 NOVEL HETEROARYL HETEROCYCLYL COMPOUNDS FOR THE TREATMENT OF AUTOIMMUNE DISEASE F. Hoffmann-La Roche AG (CH) 2021-04-21 EP disclosed
WO-2019238616-A1 NOVEL HETEROARYL HETEROCYCLYL COMPOUNDS FOR THE TREATMENT OF AUTOIMMUNE DISEASE F. HOFFMANN-LA ROCHE AG (CH) 2019-12-19 WO disclosed